Warraich, H. J., Patrick-Lake, B., Saha, A., Rashid, L., Pai, V., Abbasi, A., … Califf, R. M. (2025). Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration. J Am Coll Cardiol, 85(5), 528–535. https://doi.org/10.1016/j.jacc.2024.10.075

Warraich, Haider J., Bray Patrick-Lake, Anindita Saha, Leeda Rashid, Vinay Pai, Ali Abbasi, Matthew C. Diamond, Troy Tazbaz, and Robert M. Califf. “Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration.” J Am Coll Cardiol 85, no. 5 (February 11, 2025): 528–35. https://doi.org/10.1016/j.jacc.2024.10.075.

Warraich HJ, Patrick-Lake B, Saha A, Rashid L, Pai V, Abbasi A, et al. Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration. J Am Coll Cardiol. 2025 Feb 11;85(5):528–35.

Warraich, Haider J., et al. “Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration.” J Am Coll Cardiol, vol. 85, no. 5, Feb. 2025, pp. 528–35. Pubmed, doi:10.1016/j.jacc.2024.10.075.

Warraich HJ, Patrick-Lake B, Saha A, Rashid L, Pai V, Abbasi A, Diamond MC, Tazbaz T, Califf RM. Digital Health Technologies for Cardiometabolic Disease and Diabetes: A Perspective From the U.S. Food and Drug Administration. J Am Coll Cardiol. 2025 Feb 11;85(5):528–535.